atazanavir sulfate has been researched along with tridemorph in 1 studies
Studies (atazanavir sulfate) | Trials (atazanavir sulfate) | Recent Studies (post-2010) (atazanavir sulfate) | Studies (tridemorph) | Trials (tridemorph) | Recent Studies (post-2010) (tridemorph) |
---|---|---|---|---|---|
1,102 | 246 | 590 | 997 | 7 | 301 |
Protein | Taxonomy | atazanavir sulfate (IC50) | tridemorph (IC50) |
---|---|---|---|
Cycloeucalenol cycloisomerase | Zea mays | 0.4 | |
Sterol-8,7-isomerase | Zea mays | 0.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bauer, JW; Breitenbach, M; Breitenbach-Koller, H; Friedrich, A; Hintner, H; Karl, T; Kitzler, CM; Krauß, J; Lottspeich, F; Mewes, W; Müller, N; Rathner, A; Rathner, P; Schernthaner, J; von Hagen, J; Wießner, M | 1 |
1 other study(ies) available for atazanavir sulfate and tridemorph
Article | Year |
---|---|
Drug Development for Target Ribosomal Protein rpL35/uL29 for Repair of LAMB3R635X in Rare Skin Disease Epidermolysis Bullosa.
Topics: Artesunate; Atazanavir Sulfate; Cell Adhesion Molecules; Epidermolysis Bullosa, Junctional; Humans; Kalinin; Molecular Docking Simulation; Protein Binding; Ribosomal Proteins; RNA, Messenger; Skin; Skin Physiological Phenomena | 2021 |